Daihan Scientific
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Daihan Scientific supplies laboratory instruments and equipment, the tools researchers use daily in scientific and medical labs, sourcing from hundreds of manufacturers worldwide and distributing tens of thousands of product types through dealer networks at home and abroad.
Its customers include research institutions, universities, and medical facilities in Korea and across roughly seventy countries. Listed on KOSDAQ, Korea's tech and small-cap board, the company operates across both distribution and in-house manufacturing, and has expanded into medical-device distribution and value-added services such as calibration, rental, and lab consulting.
Summary is AI-generated and may contain errors · figures from DART filings
The company has launched a dedicated medical-device distribution arm, Daihan Medical, building out a separate dealer network alongside its core scientific-equipment business.
Daihan Scientific in five facts
What does Daihan Scientific do?
Daihan Scientific supplies laboratory instruments and equipment, the tools researchers use daily in scientific and medical labs, sourcing from hundreds of manufacturers worldwide and distributing tens of thousands of product types through dealer networks at home and abroad.
Where is Daihan Scientific listed and in which sector?
Daihan Scientific (Korean name: 대한과학) trades under KRX code 131220 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Industrials sector, Trading & Distribution.
How large is Daihan Scientific?
Its market capitalisation was US$19.6M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Daihan Scientific's latest annual revenue and operating profit?
For fiscal year 2025, Daihan Scientific reported revenue of US$61.2M, operating profit of US$4.2M and net income of US$3.6M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 13.1% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Cash/in-kind dividend decision
Daihan Scientific declared a cash dividend of US$0.09 per share.
Dividend · Feb 27 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Daihan Scientific reported consolidated results for FY2025: revenue of US$56.6M (+13.1% year on year), operating profit of US$3.86M (+30.8% year on year) and net income of US$3.34M (+21.7% year on year).
Earnings · Feb 27